SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matria Healthcare (MATR)
MATR 2.680+0.2%Aug 20 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Thomas W. O'Brien who wrote (60)10/15/1997 10:10:00 PM
From: satish kamat   of 220
 
Thomas: The Red Chip guys are suppossed to be very good, correct? Was more of their investment hypothesis available publicly for MATR?

Zack's has three analysts following the stock:
H.D. BROUS AND CO. N/A
MORGAN KEEGAN & CO INC HOLD
CRUTTENDEN AND CO. STRONG BUY

The HD Brouse only recently updated their opinion as of 10/6/97. Which the way is when the push to recent level started. It would be interesting to get their update.

(Sptember 26, 1997) Morgan Keegan, Inc. analyst Joseph Milsap issued a 1 page Company Report on MATRIA HEALTHCR. Highlights: The third quarter estimate was upwardly revised to $0.11 per share as the company recently sustained favorable revenue and earnings momentum. The HOLD rating was maintained because of three near term catalysts: 1) possible, favorable settlement of a law suit 2) improving earnings and cash flows operations 3) improved patient diagnostics, share recapitalization, or acquisitions.
I wonder what this guy expects for a strong buy.

I like the phrase " share recapitalization"- will it be same as share repurchase program you referred in one of your earlier posts?

Much of today's selling was due to small size (200-1000) order.

Let us enjoy the ride.

satish kamat

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext